Amanote Research
Register
Sign In
RGD-modifided Oncolytic Adenovirus Exhibited Potent Cytotoxic Effect on CAR-negative Bladder Cancer-Initiating Cells
Cell Death and Disease
- United Kingdom
doi 10.1038/cddis.2015.128
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Date
May 1, 2015
Authors
Y Yang
H Xu
J Shen
Y Yang
S Wu
J Xiao
Y Xu
X-Y Liu
L Chu
Publisher
Springer Science and Business Media LLC
Related search
Potent Antitumor Effect of Tumor Microenvironment-Targeted Oncolytic Adenovirus Against Desmoplastic Pancreatic Cancer
International Journal of Cancer
Cancer Research
Oncology
842. Increased Oncolytic Ability of a Double RGD-Modified Adenovirus in Ovarian Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
GP73-regulated Oncolytic Adenoviruses Possess Potent Killing Effect on Human Liver Cancer Stem-Like Cells
Oncotarget
Oncology
A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent
Oncogene
Cancer Research
Genetics
Molecular Biology
Late-Phase miRNA-controlled Oncolytic Adenovirus for Selective Killing of Cancer Cells
Oncotarget
Oncology
800. Biological Effects of Oncolytic Adenovirus on Epithelial-Mesenchymal Transition in Human Lung Cancer Cells
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Conditionally Replicative Adenovirus Expressing a Targeting Adapter Molecule Exhibits Enhanced Oncolytic Potency on CAR-deficient Tumors
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
112. A Novel Oncolytic Adenovirus Based on Human Adenovirus Serotype 17
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery